Publication Beamlines Strategic Pillar
Yasaman Yousefi Sigari, Drew Bertwistle, Mark Boland (2021). Vertical Phase Space Measurement Progress at Canadian Light Source. Canada: University of Saskatchewan. 10.18429/JACoW-IPAC2021-MOPAB310. Materials
Cron, Brandi; Macalady, Jennifer L.; Cosmidis, Julie (2021). Organic stabilization of extracellular elemental sulfur in a Sulfurovum-rich biofilm: a new role for EPS?. Patent Number: 10.1101/2021.06.03.446708. Environment
Томас ШПРЕТЕР ФОН КРЕДЕНШТАЙН; Сержит Бхимарао ДИКСИТ; Эрик ЭСКОБАР-КАБРЕРА; Пола Ирэн ЛАРИО; Дэвид Кай Юэнь ПУН et al. (2023). DEVELOPMENT OF STABLE HETERODIMERIC ANTIBODY WITH MUTATIONS IN Fc DOMAIN. Patent Number: RU2810540C2. Health
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.